Outlook Therapeutics Inc — Cash Flow (NASDAQ:OTLK) | MetaTrader

Open full chart

Financials

Overview Relatórios Statistics

Quarterly Annual

Cash from operating activities -31.79 M-54.25 M-56.67 M-42.97 M-68.79 M-51.83 M -55.8 M Cash from investing activities -900 K-900 K———— — Cash from financing activities 37.21 M56.19 M59.59 M48.97 M60.33 M44.98 M 58.78 M Free cash flow -31.79 M-54.25 M-56.67 M-42.97 M-68.79 M-51.83 M -55.8 M

Notícias

Outlook Therapeutics discute reunião com FDA sobre medicamento bevacizumab

Outlook Therapeutics discusses FDA meeting on bevacizumab drug

Oncobiologics, Inc. (OTLK) Reports Q1 Loss, Misses Revenue Estimates

OTLK Stock Crashes 67% in a Week: Here's What You Need to Know

Outlook Therapeutics nomeia Laura Cantrell como VP de estratégia corporativa

Preço-alvo das ações da Outlook Therapeutics reduzido para US$ 0,50 pela H.C. Wainwright

Outlook Therapeutics stock price target lowered to $0.50 at H.C. Wainwright

Dow Jumps Over 300 Points On First Trading Day Of 2026: Fear & Greed Index Remains In 'Neutral Zone - Micron Technology (NASDAQ:MU), NVIDIA (NASDAQ:NVDA)

The Narrowing Pathway for Biotech Securities Fraud Claims: Lessons from Outlook Therapeutics - TipRanks.com

U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.66%

E.U.A. - Ações fecharam o pregão inalteradas e o Índice Dow Jones Industrial Average avançou 0,66%

Why Intelligent Bio Solutions Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Friday's Mid-Day Session - Aimei Health Technology (NASDAQ:AFJK), Astera Labs (NASDAQ:ALAB)